Clinical Trial

Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations

Name: Umbrella Trial of Adjuvant Therapy in Completely Resected High-risk Stage IA-IB NSCLC: Focus on Driver Mutations — clinical trial record (NCT06955325)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: UPLIFT

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This study explores how adjuvant therapy affects survival in completely resected high-risk stage IA-IB NSCLC patients with different driver gene mutations.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-04-24.

Trial Details

NCT Number	NCT06955325
Lead Sponsor	The First Affiliated Hospital of Guangzhou Medical University
Conditions	Non-Small Cell Lung Cancer
Enrollment	270 participants
Start Date	2025-05
Primary Completion	2030-12 (estimated)
Study Completion	2035-12 (estimated)
Updated on ClinicalTrials.gov	2025-05-06